News
1d
A dad who thought he had a UTI was diagnosed with stage four bladder cancer and given 24 months to live. Dad-of-two Chris Cotton, 50, started experiencing what he believed were UTI symptoms in October ...
Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics ...
Blavity on MSN1d
Prostate Cancer Has A High Survival Rate But Is More Aggressive In Black Men – Here’s What To KnowProstate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, will announce new clinical findings for ANKTIVA® ...
Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical ...
Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...
Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly ...
About High-Risk Non-Muscle-Invasive Bladder Cancer High-risk non-muscle-invasive bladder cancer is a type of non-invasive bladder cancer that is more likely to recur or spread beyond the lining of ...
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback